Halozyme Therapeutics, Inc. (HALO)
NASDAQ·Healthcare·Biotechnology
$107.35
+0.32%
Mkt Cap $13.07B
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (23 analysts)
$88.25
Range $75.00 – $95.00
Implied Upside
-17.8%
Consensus $88.25 vs current $107.35
NASDAQ·Healthcare·Biotechnology
$107.35
+0.32%
Mkt Cap $13.07B
Buy
7
Hold
1
Sell
0
Price Target (23 analysts)
$88.25
Range $75.00 – $95.00
-17.8%
Consensus $88.25 vs current $107.35